FIELD: chemistry.
SUBSTANCE: disclosed agent is a xanthine derivative of formula 1
, where R1 denotes CH3, R2 denotes CH3; R3 denotes halogens: F,Cl, Br, I; R4 denotes hydrogen; R1 denotes CH3, R2 denotes CH3; R3 denotes hydrogen, halogens: F, Cl, Br, I; R4 denotes CH2COOH; R1 denotes hydrogen, R2 denotes CH3; R3 denotes halogens: F, Cl, Br, I; R4 denotes CH3. The preferred compounds of the said agent are 8-chlorotheophylline, 8-bromotheophylline and theophylline-7-acetate. The invention also relates to a method of slowing down proliferation of tumour cells and a method of inducing differentiation in mouse melanoma B16-F10 cells. Each of the methods involves addition of an effective amount of the said agent in an effective amount, preferably in amount of 1 mM.
EFFECT: improved properties of the derivatives.
8 cl, 4 tbl, 12 dwg
Title | Year | Author | Number |
---|---|---|---|
FLUORENE DERIVATIVES, HAVING ANTIPROLIFERATIVE ACTIVITY, CELL DIFFERENTIATION MODULATORS, METHOD OF SLOWING DOWN TUMOUR CELL PROLIFERATION, METHOD OF INDUCING DIFFERENTIATION IN MOUSE MELANOMA CELLS | 2008 |
|
RU2409568C2 |
HETEROCYCLIC COMPOUNDS, HAVING ANTIPROLIFERATIVE ACTIVITY AND METHOD OF SLOWING DOWN TUMOUR CELL PROLIFERATION | 2008 |
|
RU2429232C2 |
THERAPEUTIC QUINONES | 2005 |
|
RU2411229C2 |
AZAINDOLE-INDOLE DERIVATIVES, METHODS FOR PREPARING AND USING | 2008 |
|
RU2486184C2 |
METHOD FOR EXPERIMENTAL BIOTHERAPY OF B16/F10 MELANOMA | 2022 |
|
RU2779698C1 |
PHARMACEUTICAL COMPOSITIONS CONTAINING AGONIST OR ANTAGONIST OF ADENOSINE RECEPTOR | 2000 |
|
RU2239455C2 |
TRANSESTERIFICATION METHOD FOR PRODUCTION OF SYNTHETIC CHLOROPHYLL OR BACTERIOCHLOROPHYLL DERIVATIVES | 2000 |
|
RU2250905C2 |
METHOD OF THE MELANOMA TUMOR NODES FORMATION IN THE BODY OF EXPERIMENTAL ANIMALS | 2022 |
|
RU2796892C1 |
METHODS FOR SKIN CLARIFICATION | 2013 |
|
RU2628871C2 |
UNSATURATED FATTY HYDROXY ACIDS AND USE THEREOF IN DERMATOCOSMETOLOGY | 2006 |
|
RU2440328C2 |
Authors
Dates
2011-07-20—Published
2008-12-29—Filed